Revance Therapeutics Securities Settlement
Amount not yet determined; depends on how many valid claims are submitted and the Plan of Allocation approved by the Court.
What happened
Revance Therapeutics made alleged material misrepresentations and omissions about its relationship with Teoxane SA and a tender offer and merger transaction with Crown Laboratories, Inc. The defendants deny the allegations and any liability. The settlement was reached in connection with a securities class action alleging violations of federal securities laws.
Do you qualify?
Anyone who purchased or acquired Revance Therapeutics securities during February 29, 2024 through February 6, 2025, including common stock (ticker RVNC) and 1.75% fixed coupon Convertible Senior Unsecured Notes.
How to file
Submit a Proof of Claim and Release Form either by mail (postmarked) or online no later than August 28, 2026. You can file a claim online through the settlement website. Your claim must include documentation of your securities purchases.
In the news
- ALERT: Revance Therapeutics, Inc. Investors with Significant Losses Have Opportunity to Lead Class Action Lawsuit - RVNCYahoo Entertainment · December 31, 2021
- Kessler Topaz Meltzer & Check, LLP: Important Deadline Reminder for Revance Therapeutics, Inc. Investors in Securities Fraud Class Action LawsuitYahoo Entertainment · December 30, 2021
- Revance Therapeutics, Inc. Sued for Securities Law Violations; Investors Should Contact Block & Leviton for More InformationYahoo Entertainment · December 30, 2021
- RVNC DEADLINE REMINDER: Kessler Topaz Meltzer & Check, LLP - Important LP February 8, 2022 Deadline Reminder for Revance Therapeutics, Inc.Yahoo Entertainment · December 25, 2021
Headlines via NewsAPI. ClaimWatch isn't affiliated with these publications.
New to class actions?
This summary was generated from public settlement documents and may contain errors. Confirm eligibility, deadlines, and payment terms on the official settlement website before filing. ClaimWatch is not a law firm and this is not legal advice. Filing a claim is free.
More securities settlements
View all →Mylan Securities Litigation Settlement
Mylan N.V. and certain executives (CEO Heather Bresch, President Rajiv Malik, and CFO Kenneth Parks) faced allegations of securities fraud. Defendants have denied all claims and admit no wrongdoing, but have agreed to settle for $60,000,000 to eliminate the burden and expense of continued litigation.
Robinhood Order Flow Settlement
Robinhood is settling claims that it routed customer market orders to sell equities at prices lower than the National Best Bid and market orders to buy equities at prices higher than the National Best Offer during market hours between September 1, 2016 and September 1, 2018, allegedly resulting in worse execution prices for customers. Robinhood denies all allegations of liability, fault, or wrongdoing.
Up to $17.60
Tattooed Chef Securities Settlement
Tattooed Chef, Inc. is settling a securities class action lawsuit. The defendant allegedly violated securities laws between December 15, 2020 and November 28, 2022, harming shareholders who purchased or acquired the company's common stock during that period.
Estée Lauder Securities Settlement
Shareholders of The Estée Lauder Companies Inc. allege they were damaged by conduct related to the company's publicly traded common stock during the class period from February 2022 to February 2025. The defendant's specific conduct is not detailed on this page.